newsfilter
← Latest News
Business Wire·

Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow

Vyome Therapeutics, Inc. ("Vyome"), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that it has closed the